These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36998242)

  • 1. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for Pancreatic Ductal Adenocarcinoma.
    Xu B; Dan W; Zhang X; Wang H; Cao L; Li S; Li J
    Biomed Res Int; 2022; 2022():6229462. PubMed ID: 35707377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
    Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
    Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
    Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC).
    Novitasari D; Jenie RI; Kato JY; Meiyanto E
    J Egypt Natl Canc Inst; 2021 Aug; 33(1):19. PubMed ID: 34337682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
    Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
    Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Mechanism of Sancao Yuyang Decoction in the Treatment of Oral Mucositis Based on Network Pharmacology and Experimental Validation.
    Liu Y; Ye Y; Xie G; Xu Y; Cheng M; Li C; Qu M; Zhu F
    Drug Des Devel Ther; 2023; 17():55-74. PubMed ID: 36660249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
    Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
    BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
    Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
    Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification.
    Zhao Z; Zhu Y; Long F; Ma Y; Tang Q; Wang T
    BMC Complement Med Ther; 2024 Jun; 24(1):221. PubMed ID: 38849817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
    Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
    Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
    Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining the Mechanisms of Huachansu Injection on Liver Cancer through Integrated Bioinformatics Analysis.
    Huang CY; Cheng YM; Li W; Huang YC; Luo H; Zhong C; Liu FB
    Recent Pat Anticancer Drug Discov; 2023; 18(3):408-425. PubMed ID: 35546757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
    Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.